Scary Good or Just Scary? Al in Psychiatry
Join Genomind and guest speaker, Roy H. Perlis, MD, MSc, on a journey through cutting-edge applications and the potential impact of artificial intelligence on mental health. This is your chance to explore the future of psychiatry and its intriguing possibilities! More About this Webinar Dr. Perlis is the Associate Chief for Research in the Department […]
Cannabis Conundrum – Role of Cannabis Use in Persons with Psychotic Disorders
Register for Genomind’s upcoming clinical education webinar on utilizing medical cannabis in clinical pharmacology.
What’s New About Depression in Older Adults?
Register for Genomind’s upcoming clinical education webinar on utilizing medical cannabis in clinical pharmacology.
Genomind Precision Health Platform: Literature Summary
Download a summary of the evidence supporting the genes and associated guidance on Genomind’s pharmacogenetic (PGx) test.
Pharmacogenetics: Beyond Red Light, Green Light
Register for Genomind’s upcoming clinical education webinar on the utility of PGx testing with a focus on child and adolescent psychiatry.
Using Brain Markers to Guide Novel Interventions for Mood and Cognitive Symptoms in Late-Life Depression
Dr. Faith Gunning presents on using brain markers as interventions for mood and cognitive symptoms in late-life depression.
How the COMT Gene Impacts Mental Health Treatment
What does the COMT enzyme do? COMT (catechol-O-methyltransferase) is a central enzyme that breaks down catecholamines including dopamine, norepinephrine, and epinephrine. COMT plays a vital role in regulating dopamine signaling in the prefrontal cortex where dopamine transporters are relatively sparse.1 Dopamine levels here are critical for memory, attention, judgment, and other executive functions.2,3 COMT gene […]
PGx in Practice – Psychiatric Case Roundtable
Register for Genomind’s upcoming psychiatric case study roundtable, presented by a panel of clinical experts.
Precision Prescribing: Using Genetics and Technology at the Population and Individual Level
Genomind’s Co-Chief Executive Officers discuss precision medicine for individuals and population health at the GDBHT2022.
Medical Cannabis in Clinical Pharmacology
Learn about the utilization of medical cannabis in clinical pharmacology.
How I Use Pharmacogenetics
Learn about utilizing pharmacogenetics for the treatment of mood disorders from Dr. Joseph Goldberg.
Continuing Medical Education: Pharmacogenomic Certificate Program
Earn your annual CME credits through a Pharmacogenomic Certificate Program.
Population Health and Precision Medicine
Genomind hosts guest speaker, Dr. David Nash, for a Grand Rounds presentation on the convergence of population health and precision medicine.
Attention-Deficit/Hyperactivity Disorder: Pharmacologic Treatment Options
Learn more about pharmacotherapy and how pharmacogenetic testing can help personalize treatment of ADHD.
Anxiety in the Older Adult Population: Key Considerations for Treatment
Discover how anxiety disorders impact the older adult population & why it’s necessary to consider specific patient characteristics when selecting treatment
Generalized Anxiety Disorder: Pharmacologic Treatment Options
Learn more about pharmacotherapy and how pharmacogenetic testing can help personalize treatment of generalized anxiety disorder.
Bipolar Disorder: Keys to Accurate Diagnosis and Treatment
Learn about the Keys to Accurate Diagnosis and Treatment in Bipolar Disorder.
Genomind Drug Spotlight: Lithium
Learn more about the mood stabilizer lithium and how to manage common side effects of the medication.
HLA-A & HLA-B Gene Spotlight
Learn more about the HLA-A and HLA-B genes and how genetic variability can increase an individual’s risk of developing an immune-mediated drug hypersensitivity reaction.
Principles of Psychotropic Medication Management in Pregnancy & Lactation
Learn about the the Principles of Psychotropic Medication Management in Pregnancy & Lactation.
Management of Bipolar Disorder with a Focus on Pharmacogenetics
Learn about the the Management of Bipolar Disorder with a Focus on Pharmacogenetics.
Pharmacogenetics and its Role in Psychiatric Medications
Learn more about the implementation of pharmacogenetic testing and psychiatric medications, including antidepressants, antipsychotics and mood stabilizers.
Pharmacogenomic Terminology and Nomenclature
Better understand pharmacogenomic terminology and the nomenclature systems used to identify genetic variants.
Precision Medication Management
Learn about the basics of pharmacogenetics and how to utilize precision medication management.
ABCB1 Gene Spotlight
What is the ABCB1 gene and what are its gene variants (gene mutations)? Learn about this gene and how it can impact treatment plans.
Management of ADHD with a Focus on PGx | Pharmacokinetic Genes
Learn how pharmacokinetic gene variations may impact pharmacologic treatments for ADHD.
Psychedelics in Psychiatry
Learn about psychedelic use in psychiatry from Dr. Cody Wenthur.
PGx FAQs – Roundtable Discussion
Join the Genomind Medical Affairs team for a roundtable discussion focused on mental health pharmacogenetics (PGx).
Anticholinergic Side Effects in the Older Adult Population
Learn more about drugs with anticholinergic activity, adverse effects, and the anticholinergic burden scale.
Mental Health Disorders and Comorbid Medical Conditions
Learn more about common co-occurring disorders and how pharmacogenetic testing can help healthcare providers optimize drug therapy.
